Jinan, China

Bo Pan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Pan. Retrieved from https://idiyas.com/inventor/bo-pan-k147zvkw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bo Pan: Innovator in Pharmaceutical Composition

Introduction

Bo Pan is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. His work is characterized by a focus on enhancing therapeutic efficacy through novel formulations.

Latest Patents

Bo Pan holds a patent for a composition comprising aflibercept and a variant thereof, along with related methods and uses. This patent represents a significant advancement in the treatment options available for various medical conditions. The patent showcases his expertise and commitment to improving healthcare solutions.

Career Highlights

Bo Pan is currently employed at Qilu Pharmaceutical Co., Ltd. His role at the company allows him to leverage his skills and knowledge in pharmaceutical research and development. His contributions have been instrumental in driving the company's innovative projects forward.

Collaborations

Throughout his career, Bo Pan has collaborated with esteemed colleagues, including Huanlan Zheng and Guijiang Wang. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research efforts.

Conclusion

Bo Pan's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent and collaborations reflect his dedication to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…